Literature DB >> 15179548

[A synopsis of medication for degenerative osteoarthritis].

J Grifka1, U Müller-Ladner.   

Abstract

Drug treatment options should be used before starting operative procedures for degenerative osteoarthritis. The directed use of drugs helps to convert activate arthritis to the asymptomatic phase. This article summarizes guidelines and gives an overview of the effects and problems.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15179548     DOI： 10.1007/s00132-004-0679-3

Source DB:  PubMed          Journal:  Orthopade        ISSN： 0085-4530            Impact factor:   1.087


  23 in total

1.  [Intraarticular punctures and injections: indications--prevention of infection--technique--complications].

Authors:  A Bernau; P Heeg
Journal:  Orthopade       Date:  2003-06       Impact factor: 1.087

2.  Intra-articular hyaluronan treatment for osteoarthritis.

Authors:  E George
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

Review 3.  Corticosteroids in the treatment of rheumatologic diseases.

Authors:  E Morand
Journal:  Curr Opin Rheumatol       Date:  1997-05       Impact factor: 5.006

4.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

Authors:  J D Bradley; K D Brandt; B P Katz; L A Kalasinski; S I Ryan
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

5.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

6.  Glucosamine sulfate in osteoarthritis of the knee.

Authors:  W Noack; M Fischer; K K Förster; L C Rovati; I Setnikar
Journal:  Osteoarthritis Cartilage       Date:  1994-03       Impact factor: 6.576

7.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

8.  EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  A Pendleton; N Arden; M Dougados; M Doherty; B Bannwarth; J W Bijlsma; F Cluzeau; C Cooper; P A Dieppe; K P Günther; H J Hauselmann; G Herrero-Beaumont; P M Kaklamanis; B Leeb; M Lequesne; S Lohmander; B Mazieres; E M Mola; K Pavelka; U Serni; B Swoboda; A A Verbruggen; G Weseloh; I Zimmermann-Gorska
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

9.  Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study.

Authors:  W Puhl; A Bernau; H Greiling; W Köpcke; W Pförringer; K J Steck; J Zacher; H P Scharf
Journal:  Osteoarthritis Cartilage       Date:  1993-10       Impact factor: 6.576

10.  Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis.

Authors:  Grace H Lo; Michael LaValley; Timothy McAlindon; David T Felson
Journal:  JAMA       Date:  2003-12-17       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.